# Species Identification, Virulence Factors, and Antifungal Resistance in Clinical Candida Isolates from ICU Patients

**Authors:** Paola Aparecida Alves Ferreira, Lucas Daniel Cibolli Roso, Daniel Almeida Freitas, Ana Paula Pereira Bressani, Paulo Henrique da Cruz Ferreira, Emerson Cotta Bodevan, Cristiane Rocha Fagundes Moura, Rosane Freitas Schwan, Vanessa Amaral Mendonça, Karina Teixeira Magalhães-Guedes, Cíntia Lacerda Ramos

PMC · DOI: 10.3390/microorganisms14010241 · 2026-01-21

## TL;DR

This study identifies and characterizes Candida species from ICU patients, highlighting their antifungal resistance and virulence traits.

## Contribution

The study provides new insights into the prevalence and resistance patterns of Candida species in ICU settings, emphasizing their clinical significance.

## Key findings

- C. albicans was the most prevalent Candida species among ICU isolates.
- Over half of the isolates showed resistance to fluconazole, indicating a significant antifungal resistance issue.
- Oral isolates showed higher resistance and virulence traits compared to tracheal isolates.

## Abstract

Candida spp. are important opportunistic human fungal pathogens. This study aimed to identify and characterize Candida spp. obtained from patients admitted to an Intensive Care Unit (ICU), focusing on virulence attributes and susceptibility to antifungal agents. A total of 131 isolates from oral and tracheobronchial secretions of adult ICU patients were evaluated. Phenotypic identification was performed using chromogenic culture media for Candida, followed by MALDI-TOF mass spectrometry, with representative isolates confirmed by ITS sequencing. Antifungal susceptibility to fluconazole, ketoconazole, and amphotericin B was determined only by the agar disk diffusion method, and virulence was assessed through esterase, DNase, protease, and hemolytic activity assays. C. albicans was the prevalent species, followed by C. tropicalis, C. krusei, C. glabrata, C. parapsilosis, C. dubliniensis, C. lusitaniae, and C. guilliermondii. Antifungal resistance rates reached 51.1% for fluconazole, 42.7% for ketoconazole, and 19.1% for amphotericin B, as determined by disk diffusion method. Overall, 64.9% of the isolates exhibited esterase activity, 18.3% DNase, 45.8% protease, and 67.2% exhibited hemolytic activity. Oral isolates were more frequent than tracheal isolates and demonstrated a higher prevalence of antifungal resistance and virulence traits. These findings underscore the epidemiological importance of characterizing Candida species in hospitals to better understand the yeast profile and to support adequate clinical management.

## Linked entities

- **Chemicals:** fluconazole (PubChem CID 3365), ketoconazole (PubChem CID 3823), amphotericin B (PubChem CID 1972)
- **Species:** Candida (taxon 5475)

## Full-text entities

- **Diseases:** fungal (MESH:D009181)
- **Chemicals:** ketoconazole (MESH:D007654), amphotericin B (MESH:D000666), fluconazole (MESH:D015725)
- **Species:** Nakaseomyces glabratus (species) [taxon 5478], Clavispora lusitaniae (species) [taxon 36911], Lodderomyces parapsilosis (species) [taxon 5480], Candida [taxon 1535326], Candida dubliniensis (species) [taxon 42374], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Meyerozyma guilliermondii (species) [taxon 4929], Pichia kudriavzevii (species) [taxon 4909], Homo sapiens (human, species) [taxon 9606], Candida albicans (species) [taxon 5476]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12843725/full.md

---
Source: https://tomesphere.com/paper/PMC12843725